Health Canada drug identification number

DIN 02057778 — PLENDIL 2.5 MG

PLENDIL is a tablet (extended-release) of Felodipine marketed by GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE. The full Felodipine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02057778
Brand name
PLENDIL
Active ingredient
Felodipine
Strength
2.5 MG
Dosage form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Manufacturer
GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE
Health Canada status
MARKETED
Drug class
Dihydropyridine calcium channel blocker (antihypertensive agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Felodipine products

DINBrandStrengthFormManufacturerStatus
02452383 APO-FELODIPINE 10 MG TABLET (EXTENDED-RELEASE) APOTEX INC MARKETED
02452367 APO-FELODIPINE 2.5 MG TABLET (EXTENDED-RELEASE) APOTEX INC MARKETED
02452375 APO-FELODIPINE 5 MG TABLET (EXTENDED-RELEASE) APOTEX INC MARKETED
00851787 PLENDIL 10 MG TABLET (EXTENDED-RELEASE) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE MARKETED
00851779 PLENDIL 5 MG TABLET (EXTENDED-RELEASE) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE MARKETED
02280272 SANDOZ FELODIPINE 10 MG TABLET (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
02280264 SANDOZ FELODIPINE 5 MG TABLET (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.